혈중 요산 수치의 임상적 의의

키워드

참고문헌 (96)

1. Mohamed FA, "On chronic Bright's disease, and its essential symptoms", Lancet, 1, pp.399~401 (1879)
2. Haig A, "On uric acid and arterial tension", BMJ, 1, pp.288~291 (1889)
3. Chobanian AV, "The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report", JAMA, 289, pp.2560~2572 (2003)
4. Pearson TA, "AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases", Circulation, 106, pp.388~391 (2002), American heart association science advisory and coordinating committee
5. Feig DI, "Uric acid and cardiovascular risk", N Engl J Med, 359, pp.1811~1821 (2008)
6. Alderman MH, "Uric acid and cardiovascular risk", Curr Opin Pharmacol, 2, pp.126~130 (2002)
7. Baker JF, "Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?", Am J Med, 118, pp.816~826 (2005)
8. Johnson RJ, "Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?", Hypertension, 41, pp.1183~1190 (2003)
9. National Statistical Office, "Report on the social survey: III. Statistical table (Health)" (2008), Korea National Statistical Office
10. Richards J, "Uric acid and renal disease", J Nephrol, 9, pp.160~166 (1996)
11. Kanellis J, "Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed", Nephrology (Carlton), 9, pp.394~399 (2004)
12. Fauci AS, "Harrison's principles of internal medicine. 17th ed" (2008), McGraw-Hill Medical
13. Maples KR, "Free radical metabolite of uric acid", J Biol Chem, 263, pp.1709~1712 (1988)
14. Santos CX, "Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation", Arch Biochem Biophys, 372, pp.285~294 (1999)
15. Abuja PM, "Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein", FEBS Lett, 446, pp.305~308 (1999)
16. Glantzounis GK, "Uric acid and oxidative stress", Curr Pharm Des, 11, pp.4145~4151 (2005)
17. Waring WS, "Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers", J Cardiovasc Pharmacol, 38, pp.365~371 (2001)
18. Chevion S, "Plasma antioxidant status and cell injury after severe physical exercise", Proc Natl Acad Sci U S A, 통권 : 100, pp.5119~5123 (2003)
19. Hellsten Y, "Allantoin formation and urate and glutathione exchange in human muscle during submaximal exercise", Free Radic Biol Med, 31, pp.1313~1322 (2001)
20. Koch M, "Uric acid in multiple sclerosis", Neurol Res, 28, pp.316~319 (2006)
21. Nieto FJ, "Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?", Atherosclerosis, 148, pp.131~139 (2000)
22. Parmar MS, "Uric acid and cardiovascular risk", N Engl J Med, 360, pp.539~ (2009)
23. Fang J, "Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National health and nutrition examination survey", JAMA, 283, pp.2404~2410 (2000)
24. Culleton BF, "Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study", Ann Intern Med, 131, pp.7~13 (1999)
25. Abbott RD, "Gout and coronary heart disease: the Framingham Study", J Clin Epidemiol, 41, pp.237~242 (1988)
26. Freedman DS, "Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I epidemiologic follow-up study", Am J Epidemiol, 141, pp.637~644 (1995)
27. Verdecchia P, "Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study", Hypertension, 36, pp.1072~1078 (2000)
28. De Leeuw PW, "Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial", J Am Soc Nephrol, 13, pp.2213~2222 (2002)
29. "Serum uric acid: its association with other risk factors and with mortality in coronary heart disease", J Chronic Dis, 29, pp.557~569 (1976)
30. Mustard JF, "Blood coagulation and platelet economy in subjects with primary gout", Can Med Assoc J, 89, pp.1207~1211 (1963)
31. Guzik TJ, "ole of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction", J Exp Med, 204, pp.2449~2460 (2007)
32. Conen D, "Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country", BMC Public Health, 4, pp.9~ (2004)
33. Puddu PE, "Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study", Acta Cardiol, 56, pp.243~251 (2001)
34. Moriarity JT, "Serum uric acid and risk of coronary heart disease: atherosclerosis risk in communities (ARIC) study", Ann Epidemiol, 10, pp.136~143 (2000)
35. Hu P, "Is serum uric acid level associated with all-cause mortality in high-functioning older persons: MacArthur studies of successful aging?", J Am Geriatr Soc, 49, pp.1679~1684 (2001)
36. Culleton BF, "Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study", Ann Intern Med, 131, pp.7~13 (1999)
37. Jee SH, "Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men", Eur J Cardiovasc Prev Rehabil, 11, pp.185~191 (2004)
38. Liese AD, "Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases", Epidemiology, 10, pp.391~397 (1999)
39. Strasak A, "Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men", Clin Chem, 54, pp.273~284 (2008)
40. Strasak AM, "Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study", Int J Cardiol, 125, pp.232~239 (2008)
41. Meisinger C, "Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic infl ammation in men from the general population: the MONICA", KORA cohort study, 2008, pp.28, 1186~1192
42. Messerli FH, "Serum uric acid in essential hypertension: an indicator of renal vascular involvement", Ann Intern Med, 93, pp.817~821 (1980)
43. Puig JG, "Uric acid as a cardiovascular risk factor in arterial hypertension", J Hypertens, 17, pp.869~872 (1999)
44. Friedl HP, "Role of oxygen radicals in tourniquet-related ischemia-reperfusion injury of human patients", Klin Wochenschr, 69, pp.1109~1112 (1991)
45. Feig DI, "Hyperuricemia in childhood primary hypertension", Hypertension, 42, pp.247~252 (2003)
46. Brand FN, "Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study", Am J Epidemiol, 121, pp.11~18 (1985)
47. Mazzali M, "Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism", Hypertension, 38, pp.1101~1106 (2001)
48. Feig DI, "Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial", JAMA, 300, pp.924~932 (2008)
49. Obermayr RP, "Elevated uric acid increases the risk for kidney disease", J Am Soc Nephrol, 19, pp.2407~2413 (2008)
50. Iseki K, "Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort", Am J Kidney Dis, 44, pp.642~650 (2004)
51. Iseki K, "Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects", Hypertens Res, 24, pp.691~697 (2001)
52. Tomita M, "Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers", J Epidemiol, 10, pp.403~409 (2000)
53. Kanbay M, "Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions", Int Urol Nephrol, 39, pp.1227~1233 (2007)
54. Talaat KM, "The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease", Am J Nephrol, 27, pp.435~440 (2007)
55. Kang DH, "A role for uric acid in the progression of renal disease", J Am Soc Nephrol, 13, pp.2888~2897 (2002)
56. Hunsicker LG, "Predictors of the progression of renal disease in the Modifi cation of Diet in Renal Disease Study", Kidney Int, 51, pp.1908~1919 (1997)
57. Sanchez-Lozada LG, "Effects of acute and chronic L-arginine treatment in experimental hyperuricemia", Am J Physiol Renal Physiol, 292, pp.F1238~F1244 (2007)
58. Watanabe S, "Uric acid, hominoid evolution, and the pathogenesis of saltsensitivity", Hypertension, 40, pp.355~360 (2002)
59. Rosenfeld JB, "Effect of long-term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic subjects", Adv Exp Med Biol, 41, pp.581~596 (1974)
60. Quinones Galvan A, "Effect of insulin on uric acid excretion in humans", Am J Physiol, 268, pp.E1~E5 (1995)
61. Chien KL, "Plasma uric acid and the risk of type 2 diabetes in a Chinese community", Clin Chem, 54, pp.310~316 (2008)
62. Nakanishi N, "Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers", Eur J Epidemiol, 18, pp.523~530 (2003)
63. Dehghan A, "High serum uric acid as a novel risk factor for type 2 diabetes", Diabetes Care, 31, pp.361~362 (2008)
64. Carnethon MR, "Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998", Am J Epidemiol, 158, pp.1058~1067 (2003)
65. Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classifi cation of diabetes mellitus provisional report of a WHO consultation", Diabet Med, 15, pp.539~553 (1998)
66. Chien KL, "Plasma uric acid and the risk of type 2 diabetes in a Chinese community", Clin Chem, 54, pp.310~316 (2008)
67. Sanchez-Lozada LG, "Effects of febuxostat on metabolic and renal alterations in rats with fructoseinduced metabolic syndrome", Am J Physiol Renal Physiol, 294, pp.F710~F718 (2008)
68. Nakagawa T, "A causal role for uric acid in fructoseinduced metabolic syndrome", Am J Physiol Renal Physiol, 290, pp.F625~F631 (2006)
69. Alderman MH, "Serum uric acid and cardiovascular events in successfully treated hypertensive patients", Hypertension, 34, pp.144~150 (1999)
70. Franse LV, "Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)", J Hypertens, 18, pp.1149~1154 (2000)
71. Wang JG, "Prognostic signifi cance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension", Hypertension, 37, pp.1069~1074 (2001)
72. Lehto S, "Serum uric acid is a strong predictor of stroke in patients with non-insulindependent diabetes mellitus", Stroke, 29, pp.635~639 (1998)
73. Dehghan A, "High serum uric acid as a novel risk factor for type 2 diabetes", Diabetes Care, 31, pp.361~362 (2008)
74. Anker SD, "Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging", Circulation, 107, pp.1991~1997 (2003)
75. Weir CJ, "Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke", Stroke, 34, pp.1951~1956 (2003)
76. Bickel C, "Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease", Am J Cardiol, 89, pp.12~17 (2002)
77. Ruilope LM, "Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome", J Hypertens, 25, pp.1711~1718 (2007)
78. Fang J, "Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992: National Health and Nutrition Examination Survey", JAMA, 283, pp.2404~2410 (2000)
79. Niskanen L, "Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study", Diabetes Care, 29, pp.709~711 (2006)
80. Niskanen LK, "Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study", Arch Intern Med, 164, pp.1546~1551 (2004)
81. Masuo K, "Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation", Hypertension, 42, pp.474~480 (2003)
82. Forman JP, "Plasma uric acid level and risk for incident hypertension among men", J Am Soc Nephrol, 18, pp.287~292 (2007)
83. Krishnan E, "Hyperuricemia and incidence of hypertension among men without metabolic syndrome", Hypertension, 49, pp.298~303 (2007)
84. Mazzali M, "Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism", Am J Physiol Renal Physiol, 282, pp.F991~F997 (2002)
85. Wheeler JG, "Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis", PLoS Med, 2, pp.e76~ (2005)
86. Athyros VG, "Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study", Am J Kidney Dis, 43, pp.589~599 (2004)
87. Hoieggen A, "The impact of serum uric acid on cardiovascular outcomes in the LIFE study", Kidney Int, 65, pp.1041~1049 (2004)
88. Manttari M, "Effects of hypertension and dyslipidemia on the decline in renal function", Hypertension, 26, pp.670~675 (1995)
89. Youssef F, "The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease", Angiology, 5, pp.53~62 (2004)
90. Siu YP, "Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level", Am J Kidney Dis, 47, pp.51~59 (2006)
91. George J, "High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid", Circulation, 114, pp.2508~2516 (2006)
92. Waring WS, "Lowering serum urate does not improve endothelial function in patients with type 2 diabetes", Diabetologia, 50, pp.2572~2579 (2007)
93. Hare JM, "Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study", J Am Coll Cardiol, 51, pp.2301~2309 (2008)
94. Weimert NA, "Allopurinol as a cardioprotectant during coronary artery bypass graft surgery", Ann Pharmacother, 37, pp.1708~1711 (2003)
95. Cappola TP, "Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy", Circulation, 104, pp.2407~2411 (2001)
96. Struthers AD, "Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study", Heart, 87, pp.229~234 (2002)

관련 논문AI추천